Literature DB >> 25346046

Good-enough level and dose-effect models: Variation among outcomes and therapists.

Jesse J Owen1, Jill Adelson1, Stephanie Budge1, Stephen M Kopta2, Robert J Reese3.   

Abstract

OBJECTIVE: The current study examined the good-enough level (GEL) and dose-effect model on three outcome variables: well-being, symptom distress, and life functioning, while accounting for therapist effects. The dose-effect model assumes the rate of change is consistent across clients, and the GEL model assumes that the rate of change will vary according to the total length of treatment.
METHOD: The sample included 13,664 clients who completed 2-100 sessions of therapy.
RESULTS: The GEL model was a better fit to the data compared to the dose-effect model for all outcomes. There were fewer changes in life functioning compared to well-being and symptom distress for clients. There were significant therapist effects for changes in symptom distress and life functioning, but not for the rates of change in well-being.
CONCLUSION: Therapists should consider the rates of change for their own clients as well as by outcome.

Keywords:  Dose-Effect; Good-Enough Level; Multilevel-Modeling; Therapieoutcomes; dose-effect; dose-effetto; esiti di terapia; good-enough level; livello sufficientement buono; modelli multilivello; multilevel modeling; therapy outcomes

Mesh:

Year:  2014        PMID: 25346046     DOI: 10.1080/10503307.2014.966346

Source DB:  PubMed          Journal:  Psychother Res        ISSN: 1050-3307


  8 in total

1.  Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders.

Authors:  Jennifer M Boggs; Richard C Lindrooth; Catherine Battaglia; Arne Beck; Debra P Ritzwoller; Brian K Ahmedani; Rebecca C Rossom; Frances L Lynch; Christine Y Lu; Beth E Waitzfelder; Ashli A Owen-Smith; Gregory E Simon; Heather D Anderson
Journal:  Gen Hosp Psychiatry       Date:  2019-11-17       Impact factor: 3.238

2.  Identifying attendance patterns in a smoking cessation treatment and their relationships with quit success.

Authors:  Jolene Jacquart; Santiago Papini; Michelle L Davis; David Rosenfield; Mark B Powers; Georita M Frierson; Lindsey B Hopkins; Scarlett O Baird; Bess H Marcus; Timothy S Church; Michael W Otto; Michael J Zvolensky; Jasper A J Smits
Journal:  Drug Alcohol Depend       Date:  2017-03-06       Impact factor: 4.492

3.  Trajectories of change of youth depressive symptoms in routine care: shape, predictors, and service-use implications.

Authors:  Elisa Napoleone; Chris Evans; Praveetha Patalay; Julian Edbrooke-Childs; Miranda Wolpert
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-03-27       Impact factor: 4.785

4.  Payment schemes and treatment responses after a demand shock in mental health care.

Authors:  Rudy Douven; Minke Remmerswaal; Tobias Vervliet
Journal:  Health Econ       Date:  2021-09-07       Impact factor: 2.395

5.  Potential predictive factors for successful referral from specialist mental-health services to less intensive treatment: A concept mapping study.

Authors:  Thijs Beckers; Bauke Koekkoek; Giel Hutschemaekers; Bea Tiemens
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

6.  Clinical outcomes of psychotherapy dropouts: does dropping out of psychotherapy necessarily mean failure?

Authors:  Rodrigo T Lopes; Miguel M Gonçalves; Dana Sinai; Paulo P Machado
Journal:  Braz J Psychiatry       Date:  2017-08-30       Impact factor: 2.697

7.  Psychotherapy and depressive symptom trajectories among VA patients: Comparing dose-effect and good-enough level models.

Authors:  Aaron A Lee; Rebecca K Sripada; Andrew C Hale; Dara Ganoczy; Ranak B Trivedi; Bruce Arnow; Paul N Pfeiffer
Journal:  J Consult Clin Psychol       Date:  2021-05

8.  Cost-Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation.

Authors:  Mathias Baumann; Tom Stargardt; Simon Frey
Journal:  Appl Health Econ Health Policy       Date:  2020-08       Impact factor: 2.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.